Evidence map›Paper›PMID 40606853›Full record

ArticleRheumatology and immunology research2025

Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated.

Giulia Micheli, Lorenzo Salvati, Boaz Palterer, Emanuele Vivarelli, Alessio Mazzoni, Nila Volpi, Alessandra Vultaggio, Andrea Matucci, Lorenzo Cosmi, Daniele Cammelli and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology and immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia MicheliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0009-0004-8115-3603
Lorenzo SalvatiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Boaz PaltererDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Emanuele VivarelliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Alessio MazzoniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Nila VolpiNeurology and Neurophysiopathology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Alessandra VultaggioDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Andrea MatucciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Lorenzo CosmiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Daniele CammelliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Paola ParronchiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40606853
PMCPMC12212632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.